| Phenol, 3-(4-chloro-2-quinazolinyl)-, 1-acetate |
3-(4-氯喹唑啉-2-基)苯基乙酸酯 |
911417-24-8 |
| 2-Thiophenecarboxylic acid, 5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)- |
5-氯-4-(4-氯-1-甲基-1H-吡唑-5-基)噻吩-2-羧酸 |
1047630-61-4 |
| Phosphonic acid, [[3,5-dimethoxy-4-(1-methylethyl)phenyl]methyl]-, diethyl ester (9CI) |
P-[3,5-二甲氧基-4-(2-丙基）苯基]-甲基磷酸二乙酯 |
443982-76-1 |
| (Z)-3-(3-(3,5-bis(trifluoroMethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid |
KPT-330中间体 |
1388842-44-1 |
| ARRY-334543 |
泛EGFR小分子抑制剂(VARLITINIB) |
845272-21-1 |
| GSK2141795 |
UPROSERTIB |
1047634-65-0 |
| 1,2,3,6-TETRAHYDRO-1-METHYL-4-(2,4,6-TRIMETHOXYPHENYL)-PYRIDINE |
113225-07-3 |
113225-07-3 |
| (8S,10S)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-10-[5-hydroxy-4-[(2S)-2-methoxymorpholin-4-yl]-6-methyl-oxan-2-yl]oxy-1-methoxy-9,10-dihydro-7H-tetracene-5,12-dione |
(8S,10S)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-10-[5-hydroxy-4-[(2S)-2-methoxymorpholin-4-yl]-6-methyl-oxan-2-yl]oxy-1-methoxy-9,10-dihydro-7H-tetracene-5,12-dione |
108943-08-4 |
| PYRAZOLO[1,5-A]PYRIDINE-2-CARBALDEHYDE |
吡唑并[1,5-A]吡啶-2-甲醛 |
885275-10-5 |
| 3-PIPERIDINOL, 1-METHYL-4-(2,4,6-TRIMETHOXYPHENYL)-, (3S,4R)- |
(3R,4R)-4-(2,4,6-三甲氧基苯基)哌啶-3-醇 |
113225-19-7 |
| 3-PIPERIDINONE, 1-METHYL-4-(2,4,6-TRIMETHOXYPHENYL)- |
1-甲基-4-(2,4,6-三甲氧基苯基)-3-哌啶酮 |
113225-10-8 |
| N-OCTYLMONOOXYETHYLENE |
n-辛基-单氧乙烯 |
10020-43-6 |
| 4-Nitrobenzophenone |
4-硝基二苯甲酮 |
1144-74-7 |
| N-(4-iodophenyl)methanesulfonamide |
N-(4-碘苯基)甲烷磺酰胺 |
102294-59-7 |
| Nemorubicin |
奈莫柔比星 |
108852-90-0 |
| 4-MORPHOLINECARBOXAMIDINE |
吗啉-4-甲脒 |
17238-66-3 |
| Omarigliptin (MK-3102) |
奥格列汀（MK-3102） |
1226781-44-7 |
| 2-methyl-2-methylsulfonyl-propane |
2-甲基-2-(甲基磺酰基)丙烷 |
14094-12-3 |
| METHYL 3,4-BIS(BROMOMETHYL)BENZOATE |
3,4-双(溴代甲基)苯甲酸甲酯 |
20896-23-5 |
| Methyl 4-BroMo-5-chloro-2-furoate |
4-溴-5-氯-2-糠酸甲酯 |
58235-82-8 |
QQ
